Eckert & Ziegler Strahlen- und Medizintechnik AG, headquartered in Berlin, is a globally active isotope technology company and holding company for a number of specialised subsidiaries that process radioisotopes as well as develop, manufacture and sell isotope technology components, medical technology equipment and related products.   
     

The Eckert & Ziegler Group equaled the sales level of prior quarters and recorded sales of EUR 27.2 million in the second quarter of 2010 (average per quarter 2009: EUR 25.3 million). Compared to the second quarter of 2009, net income after tax and minority interests increased by 44% to EUR 2.6 million.
      Eckert & Ziegler: Highest quarterly profit in Q2 2010
Berlin, August 3, 2010 - Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a firm specializing in medical use of radioactivity, recorded sales of EUR 27.2 million in the second quarter of 2010 (average per quarter 2009: EUR 25.3 million). Compared to the second quarter of 2009, net income after tax and minority interests increased by 44% to EUR 2.6 million. This means that the past quarter recorded the highest profit in the history of the company.